ESR2 and prostate cancer: IFG (0.5–10 μM) significantly decreased the methylation of the Estrogen receptor β (ER-β) promoter in prostate cancer (PCa), ER-β which has an inducing effect on PCa cellular metabolism (Ji et al., 2022).